CYTOSORBENTS CORP
CTSONASDAQ🏆 #3829 by market capEarnings Nov 3 · PostUS Equity
$0.36▼ $0.00 (−0.55%)
Market closed · at close1h—
24h▼ 0.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$23M
Small Cap
📈Revenue Growth (YoY)
+7.7%
Slowing
📊Gross Margin
71.0%
High
💵FCF Margin
—
⚖️P/S Ratio
0.6x
Cheap
Otter Score
59
Weak
📊
Analyst Ratings
Price
$0.3600
Total
13
Raised
0
Lowered
0
| Institution | Action | Rating | Date |
|---|---|---|---|
D. Boral Capital | Reiterated | Buy | 2026-03-26 |
HC Wainwright & Co. | Reiterated | Neutral | 2025-11-14 |
EF Hutton | Reiterated | Buy | 2024-11-08 |
B. Riley Securities | Reiterated | Buy | 2024-05-15 |
Jefferies | Reiterated | Buy | 2020-09-17 |
SVB Leerink | Reiterated | Outperform | 2020-09-01 |
B. Riley FBR | Reiterated | Buy | 2020-05-06 |
H.C. Wainwright | Reiterated | Buy | 2020-05-06 |
Maxim Group | Reiterated | Buy | 2017-08-08 |
Cowen & Co. | Reiterated | Outperform | 2017-06-07 |
Aegis Capital | Reiterated | Buy | 2016-10-26 |
MLV & Co. | Reiterated | Buy | 2015-03-05 |
WBB Securities | Reiterated | Speculative Buy → Buy | 2015-02-25 |
One row per institution, most recent rating